TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Liver Transplant
Research from J. Fortun et al broadens understanding of liver transplant
March 31st, 2009
According to recent research from Madrid, Spain, "Aspergillus galactomannan (GM) antigenemia is an early marker of invasive aspergillosis (IA), but may yield false-positive results. A prospective study, testing GM periodically in serum samples of liver transplant recipients, was performed." "An index more than or equal to 0.5 were considered positive. Positive GM in samples from patients without any other criteria of proven or probable IA was considered as false-positive. The test was performed weekly during the first month after transplantation. Three patients developed IA. In total, 414 serum samples from 85 liver transplant recipients were analyzed. Mean number of...
Source: TB & Outbreaks Week (2009-03-31)
|
